ADT Inc. (ADT)

NYQ – Real Time Price. Currency in USD

6.39

+0.09 (1.43%)

At close: Jun 26, 2026, 4:00 PM EDT

6.40

+0.01 (0.16%)

After-hours: Jun 26, 2026, 7:51 PM EDT

10.06.2026

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Barron's April–June 2026 stock picks highlight 32 names, with a focus on 19 high-yield, dividend-paying equities subjected to contrarian 'dogcatcher' analysis. Top ten dividend stocks yield 1.33%–5.16%, with Build-A-Bear (BBW) and Kingstone (KINS) showing standout projected returns of 82.16% and 239.6%, respectively. CBL & Associates (CBL) and ADT Inc. (ADT) are identified as 'safer' ideal dividend dogs, with dividends from $1K invested exceeding their share prices.

01.06.2026

Are Investors Undervaluing ADT (ADT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

28.05.2026

ADT (ADT) Upgraded to Buy: Here's Why

ADT (ADT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

21.05.2026

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Blu shouldn't be confused with Blue by ADT, or ADT Self Setup. I know, it's a mess.

16.05.2026

ADT Has A Clear AI-Driven Future (Rating Upgrade)

ADT becomes a more attractive investment following Apollo's complete exit and significant share repurchases. Despite flat revenue and EPS guidance in 2026, ADT targets a 5% revenue and 10% EPS CAGR, leveraging AI and the Origin AI acquisition for operational improvements and differentiation. My updated DCF values ADT at $10.33 per share, indicating a 50% undervaluation with an 8.5% shareholder yield.

15.05.2026

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

WHIPPANY, N.J.--(BUSINESS WIRE)--AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with mCSPC.

15.05.2026

Is ADT (ADT) Stock Undervalued Right Now?

Videos

No Data

There is no data to display

Press releases

15.05.2026

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

WHIPPANY, N.J.--(BUSINESS WIRE)--AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with mCSPC.

12.05.2026

Newsweek Recognizes ADT As Top Home Security Brand in America This Year

ADT has been recognized by Newsweek as one of its most trustworthy companies in America in 2026 and as a top home security company for customer service.

04.05.2026

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced the pricing of the previously announced secondary public offering of 102,000,366 shares of the Company's common stock.

04.05.2026

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (“ADT” or the “Company”) today announced a proposed secondary public offering of 102,000,366 shares of the Company's common stock held by certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”), which represent all the remaining shares owned by the Selling Stockholders.

ADT Inc. (ADT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ADT Inc. (ADT)

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Are Investors Undervaluing ADT (ADT) Right Now?

ADT (ADT) Upgraded to Buy: Here's Why

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Has A Clear AI-Driven Future (Rating Upgrade)

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Is ADT (ADT) Stock Undervalued Right Now?

Videos

No Data

Press releases

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Newsweek Recognizes ADT As Top Home Security Brand in America This Year

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Are Investors Undervaluing ADT (ADT) Right Now?

ADT (ADT) Upgraded to Buy: Here's Why

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Has A Clear AI-Driven Future (Rating Upgrade)

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Is ADT (ADT) Stock Undervalued Right Now?

Videos

No Data

Press releases

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Newsweek Recognizes ADT As Top Home Security Brand in America This Year

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Search stocks

ADT Inc. (ADT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ADT Inc. (ADT)

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Are Investors Undervaluing ADT (ADT) Right Now?

ADT (ADT) Upgraded to Buy: Here's Why

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Has A Clear AI-Driven Future (Rating Upgrade)

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Is ADT (ADT) Stock Undervalued Right Now?

Videos

No Data

Press releases

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Newsweek Recognizes ADT As Top Home Security Brand in America This Year

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Buy 2 Ideal June DiviDogs Per Barron's April To June Picks

Are Investors Undervaluing ADT (ADT) Right Now?

ADT (ADT) Upgraded to Buy: Here's Why

ADT Announces Yet Another DIY Home Security Line, Now With AI Features

ADT Has A Clear AI-Driven Future (Rating Upgrade)

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Is ADT (ADT) Stock Undervalued Right Now?

Videos

No Data

Press releases

AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer

Newsweek Recognizes ADT As Top Home Security Brand in America This Year

ADT Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

ADT Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase